|
Anastrozole, marketed as Arimidex, produces better results than tamoxifen
A NEW drug for breast cancer is better than current standard treatments and can prevent the disease returning for up to eight years, the world's largest trial has found.
The study comparing two anti-cancer drugs in more than 9300 women will change the way two-thirds of women with breast cancer are treated, researchers say.
Anastrozole, marketed as Arimidex, produces better results than tamoxifen, which has been a preferred treatment for post-menopausal women with hormone-sensitive early breast cancer for 25 years.
To read full article: http://www.smh.com.au/news/health/br...568326404.html
__________________
Kate
Stage IIIC Diagnosed Oct 25, 2005 (age 58)
ER/PR-, HER2+++, grade 3, Ploidy/DNA index: Aneuploid/1.61, S-phase: 24.2%
Neoadjunct chemo: 4 A/C; 4 Taxatore
Bilateral mastectomy June 8, 2006
14 of 26 nodes positive
Herceptin June 22, 2006 - April 20, 2007
Radiation (X35) July 24-September 11, 2006
BRCA1/BRCA2 negative
Stage IV lung mets July 13, 2007 - TCH
Single brain met - August 6, 2007 -CyberKnife
Oct 2007 - clear brain MRI and lung mets shrinking.
March 2008 lung met progression, brain still clear - begin Tykerb/Xeloda/Ixempra
|